News

Atrial fibrillation patients with a prior history of stroke who undergo catheter ablation lower their long-term risk of a recurrent stroke by 50 percent, according to new research from the Intermountain Medical Center Heart Institute.

Home November 14, 2016
Home
Videos | Heart Valve Technology

William Abraham, M.D., FACC, discusses advances in heart failure device treatment technologies at the Transcatheter ...

Home November 14, 2016
Home
News | Computed Tomography (CT)

Siemens Healthineers announced that University of Iowa Stead Family Children’s Hospital in Iowa City is the first facility in the United States to install the company’s Somatom Drive computed tomography (CT) system. This new high-performance scanner joins the Somatom Force and Somatom Definition Flash in the dual source segment of the company’s CT portfolio.

Home November 11, 2016
Home
News | Flat Panel Displays

Barco recently announced that Nexxis, its IP-based OR imaging management platform, is now operating in over 1,000 operating rooms worldwide.

Home November 11, 2016
Home
News | Cardiovascular Business

Siemens announced it intends to further develop its healthcare business, Siemens Healthineers, and give it even greater flexibility in implementing its growth plans. To this end, the company is planning to publicly list its healthcare business.

Home November 11, 2016
Home
News | Heart Valve Technology

November 10, 2016 — A Henry Ford Hospital cardiologist is pioneering a promising new procedure to improve the success of ...

Home November 10, 2016
Home
Technology | Point of Care Testing

Siemens Healthineers announced U.S. Food and Drug Administration (FDA) 510(k) clearance for a hand-held portable coagulation analyzer. The Xprecia Stride Coagulation Analyzer delivers fast, reliable Prothrombin Time/International Normalized Ratio (PT/INR) testing for point-of-care monitoring and management of oral anticoagulation therapy with warfarin, a vitamin K antagonist.

Home November 10, 2016
Home
News | Heart Valve Technology

NeoChord Inc. announced the first use of its DS1000 System in the United States as it enrolled the first patient in the RECHORD Trial.

Home November 10, 2016
Home
News | Cath Lab

Current ACCF/AHA guidelines recommend fibrinolysis (FL) as the preferred reperfusion strategy for ST-segment elevation myocardial infarction (STEMI) patients with expected delays of > 120 minutes from first medical contact to percutaneous coronary intervention (PCI). The guidelines recommend this be followed by transfer to a PCI center with angiography/PCI within 3-24 hours. However, assessment of reperfusion prior to angiography may not be accurate based on clinical and electrocardiogram (ECG) criteria alone. Recent data suggested increased recurrent ischemic events within the first 24 hours. The aim of this study, which was conducted from 2003-2015, was to assess the safety of very early PCI (< 3 hours) following FL.

Home November 10, 2016
Home
News | Genetic Testing

The recent, sudden death of a 13-year-old boy resulted in more than 20 relatives being incorrectly diagnosed as having a potentially lethal heart rhythm condition. This erroneous diagnosis occurred as a result of inappropriate use of genetic testing and incorrect interpretation of genetic test results, according to Mayo Clinic research published in Mayo Clinic Proceedings.

Home November 09, 2016
Home
Technology | Catheters

November 9, 2016 — Merit Medical Systems Inc. announced that it has received 510(k) clearance for the SwiftNINJA ...

Home November 09, 2016
Home
News | Heart Valve Technology

November 9, 2016 — A pioneering way to access the heart for transcatheter valve replacement has a 98 percent success ...

Home November 09, 2016
Home
Videos | Heart Valve Technology

A discussion with Michael Reardon, M.D. about the state of transcatheter aortic valve replacement (TAVR) as of late 2016 ...

Home November 09, 2016
Home
News | Cath Lab

November 9, 2016 — A dedicated stent study conducted exclusively in women and minority patients evaluated clinical ...

Home November 09, 2016
Home
News | EP Lab

Patients who undergo minimally invasive heart valve replacement, known as transcatheter aortic valve replacement (TAVR), sometimes develop heart rhythm problems that necessitate placement of a permanent pacemaker. However, when a pacemaker is needed soon after TAVR, patients often have worse outcomes than those who did not need a pacemaker, according to a study published recently in JACC: Cardiovascular Interventions. The study shows that the risks are both short- and long-term and include lengthier hospital and intensive care unit stays as well as a greater risk of death.

Home November 09, 2016
Home
Subscribe Now